Effects of Lactobacillus plantarum and Leuconostoc mesenteroides Probiotics on Human Seasonal and Avian Influenza Viruses
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Influenza viruses that cause recurrent seasonal epidemics to humans can be controlled with vaccine and antiviral therapy. However, the medical treatments often exhibit limited efficacy in the elderly or immunosuppressed individuals. In these cases, daily uptake of probiotics may be an option to bring in health benefits against influenza. Here, we demonstrate the effects of probiotics Lactobacillus plantarum (Lp) and Leuconostoc mesenteroides (Lm) against seasonal and avian influenza viruses. As assessed by the plaque size reduction of human H1N1 and avian influenza H7N9 viruses, including green fluorescent protein-tagged H1N1 strain in cells, the selected Lp and Lm strains restrained viral replication in mouse lungs with statistical significance. Against lethal viral challenge, the Lp and Lm strains exhibited their beneficial effects by increasing the mean days and rates of survival of the infected mice. These results suggest that, despite rather narrow ranges of protective efficacy, the dietary supplement of Lactobacillus and Leuconostoc probiotics may promote health benefits against influenza.
Abstract
Influenza viruses that cause recurrent seasonal epidemics to humans can be controlled with vaccine and antiviral therapy. However, the medical treatments often exhibit limited efficacy in the elderly or immunosuppressed individuals. In these cases, daily uptake of probiotics may be an option to bring in health benefits against influenza. Here, we demonstrate the effects of probiotics Lactobacillus plantarum (Lp) and Leuconostoc mesenteroides (Lm) against seasonal and avian influenza viruses. As assessed by the plaque size reduction of human H1N1 and avian influenza H7N9 viruses, including green fluorescent protein-tagged H1N1 strain in cells, the selected Lp and Lm strains restrained viral replication in mouse lungs with statistical significance. Against lethal viral challenge, the Lp and Lm strains exhibited their beneficial effects by increasing the mean days and rates of survival of the infected mice. These results suggest that, despite rather narrow ranges of protective efficacy, the dietary supplement of Lactobacillus and Leuconostoc probiotics may promote health benefits against influenza.
참고문헌 (48)
- Palese P, "Influenza: old and new threats", Nat. Med., 10, pp.S82~S87 (2004)[DOI]
- Neumann G, "The first influenza pandemic of the new millennium", Influenza Other Respir. Viruses, 5, pp.157~166 (2011)[DOI]
- Webster RG, "Continuing challenges in influenza", Ann. N. Y. Acad. Sci., 1323, pp.115~139 (2014)[DOI]
- Lam TT, "The genesis and source of the H7N9 influenza viruses causing human infections in China", Nature, 502, pp.241~244 (2013)[DOI]
- Wright PF, "Orthomyxoviruses; Fields Virology, 6th Ed. Ch. 41" (2013), Lippincott Williams & Wilkins
- Krammer F, "Is it possible to develop a "universal" influenza virus vaccine? Toward a universal influenza virus vaccine: potential target antigens and critical aspects for vaccine development", Cold Spring Harb. Perspect. Biol., 2017, pp.a028845~ (2017)
- Hill D, "Recent advances in microbial fermentation for dairy and health", F1000Res, 6, pp.751~ (2017)[DOI]
- MacDonald TT, "Probiotics and the immune response to vaccines", Proc. Nutr. Soc., 69, pp.442~446 (2010)[DOI]
- de Vrese M, "Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial", Vaccine, 24, pp.6670~6674 (2006)[DOI]
- Guillemard E, "Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial", Br. J. Nutr., 103, pp.58~68 (2010)[DOI]
- Boge T, "A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials", Vaccine, 27, pp.5677~5684 (2009)[DOI]
- Van Puyenbroeck K, "Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: a randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents", Am. J. Clin. Nutr., 95, pp.1165~1171 (2012)[DOI]
- Pessione E, "Bioactive molecules released in food by lactic acid bacteria: encrypted peptides and biogenic amines", Front. Microbiol., 7, pp.876~ (2016)
- Cho J, "Microbial population dynamics of kimchi, a fermented cabbage product", FEMS Microbiol. Lett., 257, pp.262~267 (2006)[DOI]
- Jung JY, "Kimchi microflora: history, current status, and perspectives for industrial kimchi production", Appl. Microbiol. Biotechnol., 98, pp.2385~2393 (2014)[DOI]
- Choi CY, "Anti-inflammatory potential of a heat-killed Lactobacillus strain isolated from kimchi on house dust mite-induced atopic dermatitis in NC", Nga mice, 2017, pp.123, 535~543
- 박세희, "Effects of heat-killed Lactobacillus plantarum against influenza viruses in mice", The Journal of Microbiology, 56(2), pp.145~149 (2018), 한국미생물학회[DOI]
- 이윤두, "Differential Cytokine Regulatory Effect of Three Lactobacillus Strains Isolated from Fermented Foods", Journal of Microbiology and Biotechnology, 26(9), pp.1517~1526 (2016), 한국미생물·생명공학회[DOI]
- 곽민규, "Cyclic Dipeptides from Lactic Acid Bacteria Inhibit Proliferation of the Influenza A Virus", The Journal of Microbiology, 51(6), pp.836~843 (2013), 한국미생물학회[DOI]
- Maeda N, "Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice", Int. Immunopharmacol., 9, pp.1122~1125 (2009)[DOI]
- Kiso M, "Protective efficacy of orally administered, heatkilled Lactobacillus pentosus b240 against influenza A virus", Sci. Rep., 3, pp.1563~ (2013)[DOI]
- Goto H, "Anti-influenza virus effects of both live and nonlive Lactobacillus acidophilus L-92 accompanied by the activation of innate immunity", Br. J. Nutr., 110, pp.1810~1818 (2013)[DOI]
- 김진일, "Surface glycoproteins determine the feature of the 2009 pandemic H1N1 virus", BMB Reports, 45(11), pp.653~658 (2012), 생화학분자생물학회
- Kim JI, "Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution", J. Virol., 87, pp.7539~7549 (2013)[DOI]
- Park S, "Adaptive mutations of neuraminidase stalk truncation and deglycosylation confer enhanced pathogenicity of influenza A viruses", Sci. Rep., 7, pp.10928~ (2017)[DOI]
- Manicassamy B, "Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus", Proc. Natl. Acad. Sci. USA, 107, pp.11531~11536 (2010)[DOI]
- 김진일, "GFP-Expressing Influenza A Virus for Evaluation of the Efficacy of Antiviral Agents", The Journal of Microbiology, 50(2), pp.359~362 (2012), 한국미생물학회[DOI]
- Lee I, "Single PA mutation as a high yield determinant of avian influenza vaccines", Sci. Rep., 7, pp.40675~ (2017)[DOI]
- Park S, "Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses", Biochem. Biophys. Res. Commun., 440, pp.14~19 (2013)[DOI]
- "Disease burden of influenza"[URL]
- Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO, "World Health Organization (WHO)", ~ (2018)
- "H7N9 situation" (2018)[URL]
- Fiore AE, "Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the Advisory Committee on Immunization Practices (ACIP)", MMWR Recomm. Rep., 60, pp.1~24 (2011)
- "Seasonal influenza vaccine effectiveness, 2005-2018" (2018)[URL]
- Nachbagauer R, "Universal influenza virus vaccines and therapeutic antibodies", Clin. Microbiol. Infect., 23, pp.222~228 (2017)[DOI]
- Harding AT, "Efforts to improve the seasonal influenza vaccine", Vaccines (Basel), 6, pp.E19~ (2018)[DOI]
- Naesens L, "Antiviral therapies on the horizon for influenza", Curr. Opin. Pharmacol., 30, pp.106~115 (2016)[DOI]
- 박세희, "Antiviral Agents Against Influenza Viruses", Journal of Bacteriology and Virology, 42(4), pp.284~293 (2012), 대한미생물학회[DOI]
- Zimmermann P, "The influence of probiotics on vaccine responses - a systematic review", Vaccine, 36, pp.207~213 (2018)[DOI]
- Vitetta L, "Adjuvant probiotics and the intestinal microbiome: enhancing vaccines and immunotherapy outcomes", Vaccines (Basel), 5, pp.50~ (2017)[DOI]
- Chen MF, "Pretreatment with a heat-killed probiotic modulates monocyte chemoattractant protein-1 and reduces the pathogenicity of influenza and enterovirus 71 infections", Mucosal Immunol, 10, pp.215~227 (2017)[DOI]
- Starosila D, "Anti-influenza activity of a Bacillus subtilis probiotic strain", Antimicrob. Agents Chemother, 61, pp.e00539~17 (2017)
- Demicheli V, "Vaccines for preventing influenza in the elderly", Cochrane Database Syst. Rev., 2 (2018)
- Bitterman R, "Influenza vaccines in immunosuppressed adults with cancer", Cochrane Database Syst. Rev., 2 (2018)
- Yeh TL, "The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trials", Drug Des Devel. Ther., 12, pp.217~230 (2018)[DOI]
- Jung YJ, "Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection", Sci. Rep., 7, pp.17360~ (2017)[DOI]
- Lei WT, "Effect of probiotics and prebiotics on immune response to influenza vaccination in adults: a systematic review and meta-analysis of randomized controlled trials", Nutrients, 9, pp.1175~ (2017)[DOI]
- Palese P, "Characterization of temperature sensitive influenza virus mutants defective in neuraminidase", Virology, 61, pp.397~410 (1974)[DOI]
